Perrigo (PRGO)

Competitors to Perrigo (PRGO)

AbbVie 

Perrigo and AbbVie operate within the pharmaceutical sector but focus on different market segments, with Perrigo mainly targeting the OTC market and AbbVie concentrating on prescription pharmaceuticals, particularly in specialty and biologics. They overlap in the consumer health domain, where Perrigo's portfolio includes OTC medications that may be substitutes for some of AbbVie's prescription drugs. AbbVie enjoys a competitive edge due to its strong pipeline of biopharmaceuticals and advanced research capabilities, differentiating it largely from Perrigo's generic-oriented business model.

Johnson & Johnson 

Perrigo and Johnson & Johnson both operate in the consumer health products space, offering a range of over-the-counter (OTC) medications and personal care products. While Perrigo focuses predominantly on private label products and generic formulations, J&J leverages its strong brand equity and extensive R&D capabilities to develop innovative consumer health products. J&J holds a competitive advantage due to its established brand recognition, larger market share, and diversified product portfolio that includes prescription drugs and medical devices alongside OTC offerings.

Procter & Gamble 

Perrigo competes with Procter & Gamble primarily in the personal care and OTC health products market. While Perrigo offers a variety of generic and store-brand products that cater to consumers looking for lower-priced alternatives, P&G relies on its premium brands and significant marketing efforts to maintain market share. P&G's competitive advantage lies in its extensive global distribution networks, strong brand loyalty, and innovation in product development, rendering it a leader in consumer health products compared to Perrigo's more cost-focused strategy.

Teva Pharmaceutical Industries 

Perrigo and Teva both operate in the generics space, with Teva being one of the largest generic pharmaceutical manufacturers globally. They compete mainly on the cost and accessibility of generic and OTC medications. While Perrigo emphasizes consumer health products and has a robust private-label business, Teva's extensive experience in the prescription drug segment and larger scale of operations provide it with a competitive advantage. Teva's strong research foundation and comprehensive product offerings allow it to capture a significant share of the generic pharmaceutical market, positioning it ahead of Perrigo.